Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 108 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 7151101

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  2. US 7132420

    Aspartic protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  3. US 7132392

    Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted
  4. US 7125845

    Aza-peptide macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Oct 24, 2006 · Expires Oct 19, 2026

    granted
  5. US 7122552

    Inhibitors of JAK and CDK2 protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 17, 2006 · Expires Oct 12, 2026

    granted
  6. US 7119200

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  7. US 7119105

    Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

    The Regents of the University of California · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  8. US 7115739

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  9. US 7115637

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  10. US 7109172

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 19, 2006 · Expires Sep 14, 2026

    granted
  11. US 7098216

    Thiazolopyrimidines useful as TNFα inhibitors

    The Regents of the University of California · Granted Aug 29, 2006 · Expires Aug 24, 2026

    granted
  12. US 7098330

    Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 29, 2006 · Expires Aug 24, 2026

    granted
  13. US 7091343

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 15, 2006 · Expires Aug 10, 2026

    granted
  14. US 7087603

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 8, 2006 · Expires Aug 3, 2026

    granted
  15. US 7087642

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 8, 2006 · Expires Aug 3, 2026

    granted
  16. US 7084271

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Aug 1, 2006 · Expires Jul 27, 2026

    granted
  17. US 7084159

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 1, 2006 · Expires Jul 27, 2026

    granted
  18. US 7078209

    CAK inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 18, 2006 · Expires Jul 13, 2026

    granted
  19. US 7078525

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 18, 2006 · Expires Jul 13, 2026

    granted
  20. US 7078508

    Ixodes scapularis tissue factor pathway inhibitor

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 18, 2006 · Expires Jul 13, 2026

    granted
  21. US 7074765

    Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  22. US 7074782

    Carbamate caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  23. US 7074924

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  24. AU 2001289696

    New use of lipase inhibitors

    CHEPLAPHARM ARZNEIMITTEL GMBH [DE] · Granted Jul 6, 2006 · Expires Jul 1, 2026

    granted